Pharmaceutical
TORONTO, CANADA - 13 March, 2007 - Redknee Solutions Inc. , a leading provider of innovative infrastructure software that monetizes and personalizes services and content for mobile users, will be involved in two speaking sessions at IMS Asia, March 20th
02:27 Mar 13, 2007
DOR BioPharma, Inc. announced today that it has successfully completed a 1 year interim analysis in the long-term stability program of the key ingredient of RiVax, a recombinant subunit vaccine against ricin toxin intended to protect against exposure to
02:01 Mar 13, 2007
Human BioSystems , a leader in developing preservation platforms for organs and platelets, and HBS BioEnergy, a wholly owned subsidiary of HBS formed for the purpose of developing and producing biofuels, announced today the launching of a new website and
02:00 Mar 13, 2007
Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has expanded its patent coverage with newly issued patents in Canada and Europe issued by the Canadian I
02:00 Mar 13, 2007
Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has been honored by winning, for the second time, the San Diego Business Journal's 'Best Place
01:00 Mar 13, 2007
Active Biotech AB and Chelsea Therapeutics International Ltd has performed a first human micro-dosing trial of an I-3D compound.
22:37 Mar 12, 2007
Inflazyme Pharmaceuticals Ltd. . As announced on January 29, 2007, the preliminary results of the Phase 2b CAPSICS study with IPL512,602 showed no statistical or clinical difference between patients who received drug or placebo. However, the placebo resp
14:24 Mar 12, 2007
Inflazyme Pharmaceuticals Ltd. . As announced on January 29, 2007, the preliminary results of the Phase 2b CAPSICS study with IPL512,602 showed no statistical or clinical difference between patients who received drug or placebo. However, the placebo resp
14:23 Mar 12, 2007
POUR DIFFUSION AU CANADA EXCLUSIVEMENT. LA DIFFUSION AUX AGENCES DE TRANSMISSION DES ETATS-UNIS OU AUX ETATS-UNIS EST INTERDITE.
14:14 Mar 12, 2007
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
14:14 Mar 12, 2007
Lifebank Corp. is pleased to announce that it has re-appointed Owen Granger as its Chief Financial Officer. Mr. Granger is a Certified Management Accountant with over 20 years of experience in senior finance and accounting positions with public reporting
13:34 Mar 12, 2007
Integra LifeSciences Holdings Corporation announced today that it will host an Analyst Forum on Monday, April 16, 2007 at 10:00 AM Eastern Time at the Hilton Garden Inn in Washington, D.C. The meeting will be hosted by Stuart Essig, Integra LifeSciences'
13:30 Mar 12, 2007
Chemaphor Inc. , a biotechnology research and development company, today announced the completion of its private placement providing gross proceeds of $1 million. This represents the maximum intended placement amount as previously announced on January 12
12:04 Mar 12, 2007
Chemaphor Inc. , a biotechnology research and development company, today announced the completion of its private placement providing gross proceeds of $1 million. This represents the maximum intended placement amount as previously announced on January 12
12:00 Mar 12, 2007
SinoFresh HealthCare, Inc. , a pharmaceutical development and consumer product company specializing in upper respiratory medications, is pleased to announce today the appointment of Raymond A. Zipprich, CPA, Thomas M. Fitzgerald, Esq., and Bruce W. Simps
11:30 Mar 12, 2007
36167 - 36181 of 43022 Stories
<<
<
Next 15 Pharmaceutical
>
>>
Search News
Daily News
